Halozyme Therapeutics
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (September 2008) |
| company_type = Public (NASDAQ: HALO) | |
| Industry | Biopharmaceutical |
|---|---|
| Founded | 1998 |
| Headquarters | San Diego, California, USA |
| Key people | Jonathan E. Lim, President & CEO |
| Products | Biologics |
| Revenue | |
| Employees | 130 |
| Website | www.halozyme.com |
Halozyme Therapeutics, based in San Diego, California, is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets.
